{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:40Z","timestamp":1793210860517,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018163","name":"Margareta af Ugglas Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.msard.2024.105637","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:49:19Z","timestamp":1714535359000},"page":"105637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Concomitant autoimmunity and risk of multiple sclerosis disability worsening"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-0952","authenticated-orcid":false,"given":"Stefanie","family":"Binzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Manouchehrinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.msard.2024.105637_bib0001","first-page":"267","article-title":"Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects","volume":"11","author":"Ashtari","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"7374","key":"10.1016\/j.msard.2024.105637_bib0002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.msard.2024.105637_bib0003","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.0000000000002564","article-title":"Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity","volume":"86","author":"Berrigan","year":"2016","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.msard.2024.105637_bib0004","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/apt.12528","article-title":"Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study","volume":"39","author":"B\u00fcsch","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjdrc-2019-001071","article-title":"Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996\u20132016","volume":"8","author":"Carstensen","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"5","key":"10.1016\/j.msard.2024.105637_bib0007","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Dis."},{"issue":"11","key":"10.1016\/j.msard.2024.105637_bib0008","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.2337\/diacare.26.11.3192","article-title":"Type 1 diabetes and multiple sclerosis: together at last","volume":"26","author":"Dorman","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.msard.2024.105637_bib0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2005.06.022","article-title":"Increased risk for demyelinating diseases in patients with inflammatory bowel disease","volume":"129","author":"Gupta","year":"2005","journal-title":"Gastroenterology"},{"issue":"199","key":"10.1016\/j.msard.2024.105637_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ane.12425","article-title":"The Swedish MS registry - clinical support tool and scientific resource","volume":"132","author":"Hillert","year":"2015","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"10.1016\/j.msard.2024.105637_bib0012","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2337\/dc06-0811","article-title":"Prevalence of diabetes in patients with multiple sclerosis","volume":"29","author":"Hussein","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/gene.2008.83","article-title":"The expanding genetic overlap between multiple sclerosis and type I diabetes","volume":"10","author":"IMSGC","year":"2009","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.msard.2024.105637_bib0014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","article-title":"Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG)","volume":"52","author":"Jakobsson","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.msard.2024.105637_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00415-016-8340-8","article-title":"Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis","volume":"264","author":"Kosmidou","year":"2017","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2024.105637_bib0016","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00415-018-8811-1","article-title":"Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study","volume":"265","author":"Lorefice","year":"2018","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2024.105637_bib0017","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1177\/1352458517690618","article-title":"Age related multiple sclerosis severity score: disability ranked by age","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2024.105637_bib0018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105637_bib0019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.msard.2024.105637_bib0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"issue":"9316","key":"10.1016\/j.msard.2024.105637_bib0021","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(02)08431-3","article-title":"Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study","volume":"359","author":"Marrosu","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2024.105637_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/ijpvm.ijpvm_44_22","article-title":"The prevalence of inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS): a systematic review and meta-analysis","volume":"14","author":"Nasirzadeh","year":"2023","journal-title":"Int. J. Prev. Med."},{"issue":"6","key":"10.1016\/j.msard.2024.105637_bib0023","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1352458508088936","article-title":"Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark","volume":"14","author":"Nielsen","year":"2008","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2024.105637_bib0024","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archneur.63.7.1001","article-title":"Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study","volume":"63","author":"Nielsen","year":"2006","journal-title":"Arch Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105637_bib0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.105637_bib0026","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2337\/db06-1555","article-title":"Toward further mapping of the association between the IL2RA locus and type 1 diabetes","volume":"56","author":"Qu","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.msard.2024.105637_bib0027","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00415-019-09257-5","article-title":"Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease","volume":"266","author":"Richter","year":"2019","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.105637_bib0028","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/1352458512438240","article-title":"Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis","volume":"18","author":"Roshanisefat","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105637_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604179","article-title":"The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology","volume":"11","author":"Rutsch","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2024.105637_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrrheum.2009.42","article-title":"Genetics: unraveling the genetics of autoimmune disease","volume":"5","author":"Vyse","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.msard.2024.105637_bib0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2012.07698.x","article-title":"Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin-induced diabetes detected using in vivo \u00b9H MR spectroscopy at 9.4 T","volume":"121","author":"Wang","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2024.105637_bib0032","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","article-title":"Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis","volume":"8","author":"Weinstock-Guttman","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2024.105637_bib0033","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.166.4.2831","article-title":"Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis","volume":"166","author":"Winer","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0034","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1038\/s41467-021-25768-0","article-title":"Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.msard.2024.105637_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-024-01776-w","article-title":"Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients","volume":"29","author":"Yaqubi","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"8","key":"10.1016\/j.msard.2024.105637_bib0036","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458513515081","article-title":"Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease","volume":"20","author":"Z\u00e9phir","year":"2014","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T12:05:32Z","timestamp":1720872332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":36,"alternative-id":["S2211034824002141"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105637","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant autoimmunity and risk of multiple sclerosis disability worsening","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105637"}}